skip to Main Content

Avalere Analysis: 90% of Companies Offer Cost-Sharing Assistance to Exchange Enrollees, But Program Characteristics Vary Widely

  • This page as PDF


A recently-completed Avalere Health survey finds that while 90 percent of pharmaceutical and biotech manufacturers are offering cost-sharing assistance to exchange patients, the type of support, generosity and program structure vary widely.

Additionally, while most companies are beginning to transition patients off of patient assistance programs (PAPs), companies are doing so incrementally given ongoing uncertainty in the market. Avalere’s comprehensive report is now available for purchase, which provides in-depth quantitative findings and a glimpse into this rapidly evolving market.

For details, please contact your Avalere account lead or Lauren Barnes (

2023: Gain Clarity Sign Up for Our 2023 Healthcare Industry Outlook Webinar
January 18, 1 PM ET

Learn More
Register Now

Sign up to receive more insights about
Please enter your email address to be notified when new insights are published.

Back To Top